Cite
254 DSC2 IS A NEW IMMUNOHISTOCHEMICAL MARKER INDICATIVE OF SQUAMOUS CELL CARCINOMA COMPONENT IN URINARY BLADDER CANCER AND A VALUABLE PROGNOSTIC FACTOR
MLA
Hayashi, T., et al. “254 Dsc2 Is a New Immunohistochemical Marker Indicative of Squamous Cell Carcinoma Component in Urinary Bladder Cancer and a Valuable Prognostic Factor.” European Urology Supplements, vol. 10, no. 2, Mar. 2011, pp. 100–01. EBSCOhost, https://doi.org/10.1016/S1569-9056(11)60252-2.
APA
Hayashi, T., Ohara, S., Shoji, K., Teishima, J., Anami, K., Sakamoto, N., Sentani, K., Oue, N., Yasui, W., & Matsubara, A. (2011). 254 Dsc2 Is a New Immunohistochemical Marker Indicative of Squamous Cell Carcinoma Component in Urinary Bladder Cancer and a Valuable Prognostic Factor. European Urology Supplements, 10(2), 100–101. https://doi.org/10.1016/S1569-9056(11)60252-2
Chicago
Hayashi, T., S. Ohara, K. Shoji, J. Teishima, K. Anami, N. Sakamoto, K. Sentani, N. Oue, W. Yasui, and A. Matsubara. 2011. “254 Dsc2 Is a New Immunohistochemical Marker Indicative of Squamous Cell Carcinoma Component in Urinary Bladder Cancer and a Valuable Prognostic Factor.” European Urology Supplements 10 (2): 100–101. doi:10.1016/S1569-9056(11)60252-2.